Wells Fargo’s First Trust Nasdaq Pharmaceuticals ETF FTXH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $14 | Hold |
1
| – | – | ﹤0.01% | 6395 |
|
|
2025
Q1 | $29 | Hold |
1
| – | – | ﹤0.01% | 6098 |
|
|
2024
Q4 | $30 | Buy |
+1
| New | +$30 | ﹤0.01% | 6102 |
|
|
2024
Q3 | – | Sell |
-1,297
| Closed | -$35.3K | – | 6294 |
|
|
2024
Q2 | $35.3K | Buy |
+1,297
| New | +$35.3K | ﹤0.01% | 5046 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$20 | – | 6856 |
|
|
2023
Q4 | $20 | Hold |
1
| – | – | ﹤0.01% | 6774 |
|
|
2023
Q3 | $16 | Hold |
1
| – | – | ﹤0.01% | 6902 |
|
|
2023
Q2 | $30 | Hold |
1
| – | – | ﹤0.01% | 6886 |
|
|
2023
Q1 | $29 | Hold |
1
| – | – | ﹤0.01% | 6947 |
|
|
2022
Q4 | $27 | Hold |
1
| – | – | ﹤0.01% | 6876 |
|
|
2022
Q3 | $0 | Hold |
1
| – | – | ﹤0.01% | 6558 |
|
|
2022
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6725 |
|
|
2022
Q1 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6855 |
|
|
2021
Q4 | $0 | Buy |
+2
| New | – | ﹤0.01% | 6839 |
|
|
2021
Q3 | – | Sell |
-1
| Closed | – | – | 6787 |
|
|
2021
Q2 | $0 | Hold |
1
| – | – | ﹤0.01% | 6694 |
|
|
2021
Q1 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6634 |
|
|
2020
Q4 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 6279 |
|
|
2020
Q3 | $0 | Sell |
1
-1
| -50% | – | ﹤0.01% | 6118 |
|
|
2020
Q2 | $0 | Hold |
2
| – | – | ﹤0.01% | 6052 |
|
|
2020
Q1 | $0 | Hold |
2
| – | – | ﹤0.01% | 6010 |
|
|
2019
Q4 | $0 | Hold |
2
| – | – | ﹤0.01% | 5992 |
|
|
2019
Q3 | $0 | Buy |
2
+1
| +100% | – | ﹤0.01% | 5987 |
|
|
2019
Q2 | $0 | Buy |
+1
| New | – | ﹤0.01% | 5979 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 5914 |
|